Perera F
Environ Health Perspect. 1981 Dec;42:163-85. doi: 10.1289/ehp.8142163.
Benzo(a)pyrene(BaP) originating from fossil fuel and other organic combustion processes is largely adsorbed on fine particulate and hence is a widespread atmospheric pollutant. Available emissions and air quality data are based on the total weight of particulate matter without reference to size and give little information on trends and concentrations of fine particulate BaP. Greater reliance on coal, synfuels and diesel fuel for energy production and transportation will significantly increase ambient levels of BaP. Because of the particulate size, BaP is substantially deposited in the lower lung and readily eluted into surrounding tissue. After elution in the lung, BaP is metabolically activated to its electrophilic, carcinogenic from by a complex enzyme system whose activity is increased by prior exposure to air pollutants, cigarette smoke and certain drugs. The resultant diol epoxide metabolite has been shown to bind covalently with the DNA of the lung. In experimental animals, BaP is a potent initiating carcinogen whose action is enhanced by sulfur dioxide, promoting agents and carrier fine particles. The effect of small, divided doses of BaP has been shown to be greater than that of a single high dose; no threshold has been established. Epidemiological studies show that mixtures containing BaP (such as urban air, industrial emissions and cigarette smoke) are carcinogenic and may interact synergistically. Occupational studies indicate that the action of BaP-containing mixtures is enhanced in the presence of SO2. However, quantitative risk assessment for BaP is precluded by problems in extrapolating to the general population from small-scale animal studies; uncertainties in findings of epidemiology; and imprecise exposure data. Existing stationary and mobile controls preferentially remove coarse particulate matter and are inefficient collectors of the particulate BaP. In the current absence of health and environmental standards for BaP, there is little incentive to control BaP emissions. BaP meets the criteria for regulation under the Clean Air Act; however, no such BaP standards have yet been proposed.
源自化石燃料及其他有机燃烧过程的苯并(a)芘(BaP)大多吸附在细颗粒物上,因此是一种广泛存在的大气污染物。现有的排放和空气质量数据基于颗粒物的总重量,未提及粒径,几乎没有提供关于细颗粒物BaP的趋势和浓度的信息。在能源生产和运输中更多地依赖煤炭、合成燃料和柴油将显著提高环境中BaP的水平。由于颗粒物粒径的原因,BaP大量沉积在肺下部,并易于洗脱到周围组织中。在肺中洗脱后,BaP通过一个复杂的酶系统代谢活化为其亲电致癌形式,该酶系统的活性会因先前接触空气污染物、香烟烟雾和某些药物而增强。所产生的二醇环氧化物代谢物已被证明能与肺的DNA共价结合。在实验动物中,BaP是一种强效的引发致癌物,其作用会因二氧化硫、促癌剂和载体细颗粒物而增强。已表明小剂量、分次给予BaP的效果大于单次大剂量;尚未确定阈值。流行病学研究表明,含有BaP的混合物(如城市空气、工业排放物和香烟烟雾)具有致癌性,且可能产生协同作用。职业研究表明,在有二氧化硫存在的情况下,含BaP混合物的作用会增强。然而,由于从小规模动物研究推断至一般人群存在问题、流行病学研究结果存在不确定性以及暴露数据不精确,无法对BaP进行定量风险评估。现有的固定源和移动源控制措施优先去除粗颗粒物,对颗粒物BaP的收集效率较低。在目前缺乏BaP的健康和环境标准的情况下,几乎没有控制BaP排放的动力。BaP符合《清洁空气法》规定的监管标准;然而,尚未提出此类BaP标准。